Live Stocks get clobbered as Trump's China trade war intensifies. See the latest. Cboe UK • GBp Haleon plc (HLNL.XC) Follow Compare 365.50 +7.60 +(2.12%) At close: 4:29:56 PM GMT+1 All News Press Releases SEC Filings Pharma Stock Roundup: PFE's Final Haleon Stake Sale, AZN, SNY M&A Deals Pfizer sells 7.3% remaining stake in Haleon. FDA approves the expanded use of JNJ and NVS drugs. Sensodyne-maker axes diversity targets from bonuses Haleon is to axe diversity targets from its executive bonus scheme in the latest sign that UK businesses are rowing back on DEI. Pfizer Sells Remaining 7.3% Stake in Haleon for Around 3.3B Pfizer divests its 7.3% remaining stake in Haleon to institutional investors and Haleon itself. Pfizer sells 7.3% stake in Haleon for $3.3bn The disposal represents Pfizer's exit from its investment in Haleon, which originated from a JV formed with GSK in 2019. Top Midday Stories: EC Notifies Alphabet of DMA Noncompliance, Adopts Requirements for Apple; Boeing Expects Less Q1 Cash Outflow All three major US stock indexes were up in late-morning trading as investors await the Federal Rese Pfizer Sells Final Haleon Shares for $3.2B, Ends Stake in Consumer Healthcare Giant Pfizer offloads its 7.3% Haleon stake, raising $3.24B as BlackRock emerges as the new top shareholder Pfizer offloads final shares in Sensodyne maker Haleon Haleon was formed in 2019 by the merger of the consumer healthcare businesses of British pharmaceutical group GSK and US rival Pfizer. Pfizer Wraps Up Haleon Exit With $3.3 Billion Stake Sale (Bloomberg) -- Pfizer Inc. raised about £2.55 billion ($3.3 billion) through the sale of its remaining 7.3% stake in Haleon Plc, culminating a years-long separation from the maker of Sensodyne toothpaste.Most Read from BloombergWashington, DC, Region Braces for ‘Devastating’ Cuts from CongressNYC Plans for Flood Protection Without Federal FundsA Malibu Model for Residents on the Fire FrontlinesDespite Cost-Cutting Moves, Trump Plans to Remake DC in His StyleThe pharmaceutical giant offered about Pfizer sells entire Haleon stake for $3.24 billion Under the deal, Sensodyne maker Haleon has agreed to buy back 44 million shares from Pfizer, currently its largest shareholder, with 618 million shares being sold to institutional investors. The total sale represents 7.3% of the issued share capital of Haleon, which was created by the merger of GSK and Pfizer's consumer healthcare businesses in 2019. Teva Pharmaceutical Stock Scores RS Rating Upgrade Teva Pharmaceutical ADR shows improving price performance, earning an upgrade to its IBD Relative Strength Rating Pfizer to sell entire Haleon stake Pfizer will sell about 662 million ordinary shares, or 7.3%, of Haleon, created in a merger of GSK and Pfizer's consumer healthcare businesses in 2019, and spun off in 2022. Under the deal, the Sensodyne maker has agreed to buy back shares worth $220 million from Pfizer, currently its largest shareholder. As trade war intensifies, Reckitt may be more exposed than some rivals Some investors fear Reckitt may be forced to raise its prices in the United States or face higher costs as its low manufacturing capacity there compared to some rivals leaves the company more exposed to new U.S. tariffs on imports from Mexico. Reckitt, which makes Lysol cleaning products and Durex condoms, has five factories in the United States. It told Reuters in early March that it manufactures about 57% of its U.S. sales volumes locally, with the other 43% coming from places including Mexico and Southeast Asia. Jim Cramer on Haleon plc (HLN): ‘Stock Has Been Up’ We recently published an article titled Jim Cramer Discusses These 11 Stocks & President Trump’s Tariffs. In this article, we are going to take a look at where Haleon plc (NYSE:HLN) stands against the other stocks Jim Cramer discussed. In a recent appearance on CNBC’s Squawk on the Street, Jim Cramer commented on President Trump’s latest […] Why Haleon plc (HLN) Surged On Monday? We recently published a list of 10 Stocks Lead Monday’s Charge Amid Market Bloodbath. In this article, we are going to take a look at where Haleon plc (NYSE:HLN) stands against other stocks that lead Monday’s charge amid market bloodbath. The stock market kicked off the trading week in a bloodbath, erasing last week’s gains, […] Haleon PLC (HLN) (Q4 2024) Earnings Call Highlights: Strong Growth in Emerging Markets Amid ... Haleon PLC (HLN) reports robust performance in India and China, while navigating FX headwinds and inventory management issues. Haleon Full Year 2024 Earnings: EPS Misses Expectations Haleon ( LON:HLN ) Full Year 2024 Results Key Financial Results Revenue: UK£11.2b (flat on FY 2023). Net income... Is Haleon plc (HLN) the Best Low Price Pharma Stock to Invest In Right Now? We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to take a look at where Haleon plc (NYSE:HLN) stands against the other pharma stocks. The Rising Demand for Weight-Loss Medications and GLP-1 Developments Healthcare, which includes numerous businesses that offer patient […] Haleon beats Q4 organic growth estimates, but shares fall on 2025 guide Investing.com -- HALEON PLC (LON:HLN) shares slid 3% in London on Thursday after the Sensodyne toothpaste maker said its revenue growth for 2025 would be weighted toward the second half of the year. Stocks to watch this week: Berkshire Hathaway, Nvidia, Salesforce, IAG and Aston Martin Earnings preview of key companies reporting this week and what to look out for. Are Investors Undervaluing Haleon plc (LON:HLN) By 25%? Key Insights The projected fair value for Haleon is UK£5.19 based on 2 Stage Free Cash Flow to Equity Current share... Performance Overview Trailing total returns as of 4/10/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) Return HLNL.XC FTSE 100 (^FTSE) YTD -3.36% -3.18% 1-Year +13.27% -0.60% 3-Year +18.49% +3.18%